Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i anti-hbc ii assay is a chemiluminescent microparticle immunoassay (cmia) used for the qualitative detection of antibody to hepatitis b core antigen (anti-hbc) in human serum and plasma, including specimens collected post-mortem (non-heartbeating) on the alinity i analyzer. the alinity i anti-hbc ii assay is intended to be used as an aid in the diagnosis of hepatitis b infection and as a screening test to prevent transmission of hepatitis b virus (hbv) to recipients of blood, blood components, cells, tissues and organs.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i anti-hbe assay is a chemiluminescent microparticle immunoassay (cmia) used for the qualitative detection of antibody to hepatitis b e antigen (anti-hbe) in human serum and plasma on the alinity i analyzer. the alinity i anti-hbe assay is to be used as an aid in the diagnosis and monitoring of hepatitis b viral infection.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i anti-hcv assay is a chemiluminescent microparticle immunoassay (cmia) used for the qualitative detection of antibody to hepatitis c virus (anti-hcv) in human serum and plasma, including specimens collected post mortem (non-heart-beating) on the alinity i analyzer. the alinity i anti-hcv assay is intended to be used as an aid in the diagnosis of hepatitis c infection and as a screening test to prevent transmission of hepatitis c virus (hcv) to recipients of blood, blood components, cells, tissue and organs.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i bnp assay is a chemiluminescent microparticle immunoassay (cmia) used for the quantitative determination of human b-type natriuretic peptide (bnp) in human edta plasma on the alinity i analyzer. the alinity i bnp assay is intended to be used as an aid in the diagnosis and assessment of severity of heart failure.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i c-peptide assay is a chemiluminescent microparticle immunoassay (cmia) used for the quantitative determination of c-peptide in human serum, plasma and urine on the alinity i analyzer. the alinity i c-peptide assay is to be used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i ca 125 ii assay is a chemiluminescent microparticle immunoassay (cmia) used for the quantitative determination of oc 125 defined antigen in human serum and plasma on the alinity i analyzer. the alinity i ca 125 ii assay is to be used as an aid in monitoring response to therapy for patients with epithelial ovarian cancer. serial testing for patient ca 125 ii assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i ca 15-3 assay is a chemiluminescent microparticle immunoassay (cmia) used for the quantitative determination of df3 defined antigen in human serum and plasma on the alinity i analyzer. the alinity i ca 15-3 assay is to be used as an aid in the management of stage ii and iii breast cancer patients. serial testing for patient ca 15-3 assay values should be used in conjunction with other clinical methods for monitoring breast cancer.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i ca 19-9xr assay is a chemiluminescent microparticle immunoassay (cmia) used for the quantitative determination of 1116-ns-19-9 reactive determinants in human serum or plasma on the alinity i analyzer. the alinity i ca 19-9xr assay is to be used as an aid in the management of pancreatic cancer patients in conjunction with other clinical methods.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i cyfra 21-1 assay is a chemiluminescent microparticle immunoassay (cmia) used for the quantitative determination of human cytokeratin 19 fragments in human serum and plasma on the alinity i analyzer.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the alinity i dhea-s assay is a chemiluminescent microparticle immunoassay (cmia) used for the quantitative determination of dehydroepiandrosterone sulfate (dhea-s) in human serum and plasma on the alinity i analyzer.